- Home
- FLC vs INFU Comparison
FLC vs INFU Comparison
Compare FLC & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FLC | INFU |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.0M | 208.8M |
| IPO Year | 2003 | 2005 |
Fundamental Metrics
Financial Performance| Metric | FLC | INFU |
|---|---|---|
| Price | $16.72 | $9.24 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 21.4K | ★ 256.6K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $143,436,000.00 |
| Revenue This Year | N/A | $3.20 |
| Revenue Next Year | N/A | $7.31 |
| P/E Ratio | ★ N/A | $182.40 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $15.89 | $5.43 |
| 52 Week High | $18.09 | $11.04 |
Technical Indicators
Market Signals| Indicator | FLC | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 39.02 | 49.32 |
| Support Level | $16.26 | $8.57 |
| Resistance Level | $17.41 | $9.97 |
| Average True Range (ATR) | 0.22 | 0.51 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 69.34 | 38.85 |
Price Performance
Historical ComparisonAbout FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.